Symyx’s Buy of MDL Helped Q4 Revenue Rise 22 Percent; Profitability Seen for ‘08 | GenomeWeb
Symyx this week reported that higher-than-expected revenues from the MDL Information Systems business it acquired last fall helped total fourth-quarter revenue grow 22 percent.
 
Revenues from the MDL unit contributed around 19 percent to Symyx’s top line in the quarter, and CEO Isy Goldwasser said he expects the acquired business — and the nearly 1,000 new customers it gained in the acquisition — to help Symyx become profitable this year.
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.